New drug combo aims to boost brain healing after stroke
NCT ID NCT07283159
Summary
This study is testing whether adding a drug called Human Urinary Kallidinogenase (HUK) to the standard clot-busting stroke medication (tenecteplase) helps people recover better. It will involve 200 adults who have just had an ischemic stroke and received treatment within 4.5 hours. Researchers want to see if this combination improves patients' ability to function independently after their stroke.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Neurology, General Hospital of Northern Theater Command
RECRUITINGShenyang, 110016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.